Valentech Pharma Colombia S.A.S. is a healthcare and pharmaceutical company focused on licensing, regulatory registration, importation and commercialization of innovative and high-specialty therapies, particularly for rare (orphan) diseases and conditions with unmet medical needs across Latin America. The company's business segments include market access, regulatory affairs, commercial distribution and patient support services, supported by a portfolio of therapies addressing therapeutic areas such as rare cancers, endocrinology, metabolic disorders, gastrohepatology, hematology, nephrology, pulmonology and neuropediatrics. Operating from its headquarters in Bogota, Colombia, the company also maintains presence in Peru and is expanding within the region to serve broader Latin American markets. Key assets include strategic alliances with global pharmaceutical innovators, expertise in rare disease markets, digital platforms such as Valentech Access to streamline patient access to therapies, and educational initiatives through Valentech University to support medical professionals. Its strategic focus is on improving patient quality of life by ensuring access to innovative treatments, strengthening regulatory and market pathways for high-specialty medicines, and cultivating partnerships that enhance therapeutic availability throughout Latin America.
Headquarters
Carrera 7 N 77 - 07 Oficina 801
Bogota D.C.; Bogota D.C;
Postal Code: 0804
Contact Details: Purchase the Valentech Pharma Colombia Sas report to view the information.
Website: https://valentechforlife.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service